These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 39165982)

  • 1. The identification of heterogeneous reactive oxygen subtypes in esophageal squamous cell carcinoma to aid patient prognosis and immunotherapy.
    Lu Q; Yang Q; Zhao J; Li G; Zhang J; Jia C; Wan Y; Chen Y
    Heliyon; 2024 Aug; 10(15):e35235. PubMed ID: 39165982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancer demethylation-regulated gene score identified molecular subtypes, inspiring immunotherapy or CDK4/6 inhibitor therapy in oesophageal squamous cell carcinoma.
    Gao W; Liu S; Wu Y; Wei W; Yang Q; Li W; Chen H; Luo A; Wang Y; Liu Z
    EBioMedicine; 2024 Jul; 105():105177. PubMed ID: 38924839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel and robust pyroptosis-related prognostic signature predicts prognosis and response to immunotherapy in esophageal squamous cell carcinoma.
    Zhang D; Zhao F; Li J; Qin X; Li S; Niu R
    Aging (Albany NY); 2023 Aug; 15(15):7811-7830. PubMed ID: 37561524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-cell transcriptomics reveals heterogeneity in esophageal squamous epithelial cells and constructs models for predicting patient prognosis and immunotherapy.
    Li C; Song W; Zhang J; Luo Y
    Front Immunol; 2023; 14():1322147. PubMed ID: 38098487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A fibroblast-associated signature predicts prognosis and immunotherapy in esophageal squamous cell cancer.
    Ren Q; Zhang P; Zhang X; Feng Y; Li L; Lin H; Yu Y
    Front Immunol; 2023; 14():1199040. PubMed ID: 37313409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Tumor Antigens and Immune Subtypes of Esophageal Squamous Cell Carcinoma for mRNA Vaccine Development.
    Lu T; Xu R; Wang CH; Zhao JY; Peng B; Wang J; Zhang LY
    Front Genet; 2022; 13():853113. PubMed ID: 35734437
    [No Abstract]   [Full Text] [Related]  

  • 7. Genome-Wide DNA Methylation and Gene Expression Profiling Characterizes Molecular Subtypes of Esophagus Squamous Cell Carcinoma for Predicting Patient Survival and Immunotherapy Efficacy.
    Zheng Y; Gao Q; Su X; Xiao C; Yu B; Huang S; Sun Y; Wu S; Wo Y; Xu Q; Xu N; Yu H
    Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-cell profiling of response to neoadjuvant chemo-immunotherapy in surgically resectable esophageal squamous cell carcinoma.
    Ji G; Yang Q; Wang S; Yan X; Ou Q; Gong L; Zhao J; Zhou Y; Tian F; Lei J; Mu X; Wang J; Wang T; Wang X; Sun J; Zhang J; Jia C; Jiang T; Zhao MG; Lu Q
    Genome Med; 2024 Apr; 16(1):49. PubMed ID: 38566201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of TREM2-positive tumor-associated macrophages in esophageal squamous cell carcinoma: implication for poor prognosis and immunotherapy modulation.
    Li H; Miao Y; Zhong L; Feng S; Xu Y; Tang L; Wu C; Zhang X; Gu L; Diao H; Wang H; Wen Z; Yang M
    Front Immunol; 2023; 14():1162032. PubMed ID: 37187751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PLEK2 and IFI6, representing mesenchymal and immune-suppressive microenvironment, predicts resistance to neoadjuvant immunotherapy in esophageal squamous cell carcinoma.
    Liu J; Chen H; Qiao G; Zhang JT; Zhang S; Zhu C; Chen Y; Tang J; Li W; Wang S; Tian H; Chen Z; Ma D; Tian J; Wu YL
    Cancer Immunol Immunother; 2023 Apr; 72(4):881-893. PubMed ID: 36121452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFI6 depletion inhibits esophageal squamous cell carcinoma progression through reactive oxygen species accumulation via mitochondrial dysfunction and endoplasmic reticulum stress.
    Liu Z; Gu S; Lu T; Wu K; Li L; Dong C; Zhou Y
    J Exp Clin Cancer Res; 2020 Jul; 39(1):144. PubMed ID: 32727517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and characterization of prognosis-related genes in the tumor microenvironment of esophageal squamous cell carcinoma.
    Qu J; Zhao Q; Yang L; Ping Y; Zhang K; Lei Q; Liu F; Zhang Y
    Int Immunopharmacol; 2021 Jul; 96():107616. PubMed ID: 34162127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innovative prognostic modeling in ESCC: leveraging scRNA-seq and bulk-RNA for dendritic cell heterogeneity analysis.
    Shi M; Zhang H; Ma L; Wang X; Sun D; Feng Z
    Front Immunol; 2024; 15():1352454. PubMed ID: 38515748
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA damage repair profiling of esophageal squamous cell carcinoma uncovers clinically relevant molecular subtypes with distinct prognoses and therapeutic vulnerabilities.
    Zhao N; Zhang Z; Wang Q; Li L; Wei Z; Chen H; Zhou M; Liu Z; Su J
    EBioMedicine; 2023 Oct; 96():104801. PubMed ID: 37725855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
    Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
    Front Genet; 2022; 13():919389. PubMed ID: 35783281
    [No Abstract]   [Full Text] [Related]  

  • 16. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
    Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
    Front Immunol; 2021; 12():669750. PubMed ID: 34054840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prognosis model for predicting immunotherapy response of esophageal cancer based on oxidative stress-related signatures.
    Guo J; Tong C; Shi J; Li X; Chen X
    Oncol Res; 2023; 32(1):199-212. PubMed ID: 38196829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Risk Models Using Epithelial Cells Identify β-Sitosterol as a Potential Therapeutic Target Against Esophageal Squamous Cell Carcinoma.
    Zhang Z; Shang B; Mao X; Shi Y; Zhang G; Wang D
    Int J Gen Med; 2024; 17():1193-1211. PubMed ID: 38559590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stratification From Heterogeneity of the Cell-Death Signal Enables Prognosis Prediction and Immune Microenvironment Characterization in Esophageal Squamous Cell Carcinoma.
    Zhang Y; Chen Y
    Front Cell Dev Biol; 2022; 10():855404. PubMed ID: 35493093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of tumor antigens for mRNA vaccines and ferroptosis-related landscape in esophageal squamous cell carcinoma.
    Zeng Q; Chen B; Wang W
    Transl Cancer Res; 2024 Jun; 13(6):2860-2876. PubMed ID: 38988947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.